Literature DB >> 24209720

Diagnosis and treatment of osteoarthritis.

Rafaelani L Taruc-Uy1, Scott A Lynch.   

Abstract

Osteoarthritis presents in primary and secondary forms. The primary, or idiopathic, form occurs in previously intact joints without any inciting agent, whereas the secondary form is caused by underlying predisposing factors (eg, trauma). The diagnosis of osteoarthritis is primarily based on thorough history and physical examination findings, with or without radiographic evidence. Although some patients may be asymptomatic initially, the most common symptom is pain. Treatment options are generally classified as pharmacologic, nonpharmacologic, surgical, and complementary and/or alternative, typically used in combination to achieve optimal results. The goals of treatment are alleviation of symptoms and improvement in functional status. Published by Elsevier Inc.

Entities:  

Keywords:  Joint deformity; Joint inflammation; Joint pain; Joint swelling; Osteoarthritis; Osteophytes

Mesh:

Substances:

Year:  2013        PMID: 24209720     DOI: 10.1016/j.pop.2013.08.003

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  52 in total

1.  Intra-articular Injection of Chloramphenicol Reduces Articular Cartilage Degeneration in a Rabbit Model of Osteoarthritis.

Authors:  Xiaoqing Wu; Yongsong Cai; Shemin Lu; Ke Xu; Xuanren Shi; Le Yang; Zhenjian Huang; Peng Xu
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

2.  Re-irradiation for osteoarthritis-retrospective analysis of 217 joints.

Authors:  Matthias G Hautmann; Philipp Rechner; Matthias Hipp; Ulrich Neumaier; Felix Steger; Fabian Pohl; Markus Weber; Oliver Kölbl; Christoph Süß
Journal:  Strahlenther Onkol       Date:  2019-07-25       Impact factor: 3.621

Review 3.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

4.  A Significant Reduction in the Plasma Levels and Gene Expression of CCL2 in Patients with Osteoarthritis following Intervention with Krocina™.

Authors:  Samaneh Beiki; Jalil Tavakkol-Afshari; Zhaleh Shariati-Sarabi; Javad Poursamimi; Arezoo Gowhari Shabgah; Mojgan Mohammadi
Journal:  Rep Biochem Mol Biol       Date:  2022-04

5.  Effects of medications on incidence and risk of knee and hip joint replacement in patients with osteoarthritis: a systematic review and meta-analysis.

Authors:  Beibei Cui; Yuehong Chen; Yunru Tian; Huan Liu; Yupeng Huang; Geng Yin; Qibing Xie
Journal:  Adv Rheumatol       Date:  2022-06-27

6.  NEAT1/miR-146a-3p/TrkB/ShcB axis regulates the development and function of chondrocyte.

Authors:  Fanyou Ning; Shaobo Zhu; Hui Gao; Yu Deng
Journal:  Cell Cycle       Date:  2021-09-08       Impact factor: 5.173

7.  MicroRNA-142-3p Inhibits Chondrocyte Apoptosis and Inflammation in Osteoarthritis by Targeting HMGB1.

Authors:  Xiuqin Wang; Yanqing Guo; Chunyan Wang; Hong Yu; Xiuxiang Yu; Hongbo Yu
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

8.  Phase-contrast imaging with synchrotron hard X-ray of micro lesions of the cartilage of the femoral head in rabbits.

Authors:  Wei Sun; Yong Zhang; Fuqiang Gao; Zirong Li; Gang Li; Lin Pan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 9.  Roles of long non‑coding RNA in osteoarthritis (Review).

Authors:  Jicheng Wang; Yanshan Sun; Jianyong Liu; Bo Yang; Tengyun Wang; Zhen Zhang; Xin Jiang; Yongzhi Guo; Yangyang Zhang
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

10.  Quercetin Alleviates Osteoarthritis Progression in Rats by Suppressing Inflammation and Apoptosis via Inhibition of IRAK1/NLRP3 Signaling.

Authors:  Wenjun Li; Yeyang Wang; Yaqin Tang; Hanyu Lu; Yong Qi; Guitao Li; Hebei He; Fanglian Lu; Yixin Yang; Hongtao Sun
Journal:  J Inflamm Res       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.